Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats

Neuropsychopharmacology

Volumn 28, Issue 2, 2003, Pages 300-309

  Terry, Alvin V ^a,b   Hill, William D ^b   Parikh, Vinay ^b   Waller, Jennifer L ^b   Evans, Denise R ^b   Mahadik, Sahebarao P ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antipsychotics; Choline acetyltransferase; Cognitive performance; Rat; Risperidone

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CLOZAPINE; HALOPERIDOL; RISPERIDONE;

ANIMAL; ARTICLE; BEHAVIOR; BRAIN; CHOLINERGIC NERVE; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; MALE; MAZE TEST; METABOLISM; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; BRAIN; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; CLOZAPINE; HALOPERIDOL; MALE; MAZE LEARNING; RATS; RATS, WISTAR; RISPERIDONE; SPATIAL BEHAVIOR;

EID: 0037308980     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300039     Document Type: Article

References (45)

1. Angelucci F, Aloe L, Gruber HM, Fiore M, Mathe AA (2000). Chronic antipsychotic treatment selectively alters nerve growthfactor and neuropeptide Y immunoreactivity and the distribution of choline acetyltransferase in rat brain regions.Int JNeuropsychopharmacol3: 13-25.
2. Barrientos A, Marin C, Miro O, Casademont J, Gomez M, Nunes Vet al(1998). Biochemical and molecular effects of chronic HALadministration on brain and muscle mitochondria of rats.JNeurosci Res53: 475-481.
3. Bartus RT (2000). On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten ageneration following the cholinergic hypothesis.ExpNeurol163:495-529.
4. Borges LF, Iversen SD (1986).Topography of choline acetyltrans-feraseimmunoreactive neurons and fibers in the rat spinal cord.Brain Res362: 140-148.
5. Bymaster FP, Hemrick-Luecke SK, Perry KW, Fuller RW (1996). Neurochemical evidence for antagonism by olanzapine ofdopamine, serotonin, α 1-adrenergic and muscarinic receptorsin vivoin rats.Psychopharmacology124: 87-94.
6. Cadet JL, Lohr JB (1987). Free radicals and the developmental pathology of schizophrenic burnout.Integrative Psychiatry5:40-48.
7. Connaughton M, Priestley JV, Sofroniew MV, Eckenstein F, Cuello AC (1986). Inputs to motoneurons in the hypoglossal nucleus ofthe rat: light and electron microscopic immunocytochemistry forcholine acetyltransferase, substance P and enkephalins usingmonoclonal antibodies.Neuroscience17: 205-224.
8. Cuesta MJ, Peralta V, Zarzuela A (2001). Effects of olanzapine and other antipsychotics on cognitive functions in chronic schizo-phrenia: a longitudinal study.Schizophr Res48: 17-28.
9. Didriksen M (1995). Effects of antipsychotics on cognitive behavior in rats using the delayed non-match to positionparadigm.Eur J Pharmacol28: 241-250.
10. Eckenstein F, Thoenen H (1982). Production of specific antisera and monoclonal antibodies to choline acetyltransferase: char-acterization and use for identification of cholinergic neurons.EMBO J1: 363-368.
11. Friedman JI, Harvey PD, Kemether E, Byne W, Davis KL (1999).Cognitive and functional changes with aging in schizophrenia.Biol Psychiatry46: 921-928.
12. Horrobin DF (1999). The effects of antipsychotic drugs on membrane phospholipids—a possible novel mechanism ofaction of clozapine. In: Peet M, Glen I, Horrobin D (eds).Phospholipid Spectrum Disorders in Psychiatry. Marius Press:Lancashire, UK. pp 113-117.
13. Houser CR, Crawford GD, Barber RP, Salvaterra PM, Vaughn JE (1983). Organization and morphological characteristics of choli-nergic neurons: an immunocytochemical study with a monoclonalantibody to choline acetyltransferase. Brain Res266: 97-119.
14. Kapur S, Zipursky RB, Remington G (1999). Clinical and theoretical implications of 5-HT and D2 receptor occupancy ofclozapine, risperidone and olanzapine in schizophrenia.Am JPsychiatry156: 286-293.
15. Karson CN, Casanova MF, Kleinman JE, Griffin WS (1993).Choline acetyltransferase in schizophrenia.Am J Psychiatry150: 454-459.
16. Karson CN, Mrak RE, Husain MM, Griffin WS (1996). Decreased mesopontine choline acetyltransferase levels in schizophrenia.Correlations with cognitive functions.MolChemNeuropathol29: 181-191.
17. Kern RS, Green MF, Marshall Jr BD, Wirshing WC, Wirshing D, McGurk SRet al(1999).Risperidone versus HAL on secondarymemory: can newer medications aid learning?Schizophr Bull25:223-232.
18. Khan MM, Evans DR Gunna V, Scheffer RE, Parikh VV, Mahadik SP (2002). Reduced erythrocyte membrane essential fatty acidsand increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatmentwith antipsychotics.Schizophr Res58: 1-10.
19. Kinon BJ, Lieberman JA (1996). Mechanisms of action of atypical antipsychotic drugs: a critical analysis.Psychopharmacology(Berl)124: 2-34.
20. Korenovsky A, Laev H, Mukherjee S, Mahadik SP (1990). Quantitative analyses of plasma cholinesterase isozymes inHAL-treated rats.Biol Psychiatry27: 871-883.
21. Lussier I, Stip S (2001).Memory and attention deficits in drug naive patients with schizophrenia.Schizophr Res48: 45-55.
22. Mahadik SP, Laev H, Korenovsky A, Karpiak SE (1988). HAL alters rat CNS cholinergic system: enzymatic and morphologicalanalyses.Biol Psychiatry24: 199-217.
23. Mahadik SP, Mukherjee S (1996). Free radical pathology and antioxidant defense in schizophrenia: a review.Schizophr Res19: 1-18.
24. Mahadik SP, Sitasawad V, Mulchandani M (1999). Membrane peroxidation and the neuropathology of schizophrenia. In PeetM, Glen I, Horrobin D (eds).Phospholipid Spectrum Disorders inPsychiatry.Marius Press: Lancashire, UK. pp 99-111.
25. McDonald RJ, White NM (1995).Hippocampal and nonhippo-campal contributions to place learning in rats.BehavNeurosci109: 579-593.
26. McNamara RK, Skelton RW (1993). The neuropharmacological and neurochemical basis of place learning in the Morris watermaze.Brain Res Rev18: 33-49.
27. Miller R, Chouinard G (1993). Loss of striatal cholinergic neurons as a basis for tardive andL-dopa-induced dyskinesias, neuro-leptic-induced supersensitivity psychosis and refractory schizo-phrenia.Biol Psychiatry34: 713-738.
28. Moore NA, Calligaro DO, Wong DT, Bymaster F, Tye NC (1993).The pharmacology of olanzapine and other new antipsychoticagents.CurrOpin Invest2: 299.
29. Morris RGM (1984). Development of a water-maze procedure for studying spatial learning in the rat.J Neurosci Methods11: 4760.
30. Parikh V, Khan MM, White JR, Buckley PF, Mahadik SP (2002). Atypical antipsychotics such as risperidone and clozapine do notinduce the oxidative stress and the lipid peroxidation similar toHAL in rats.Biol Psychiatry51: 184.
31. Paxinos G, Watson CR (1998).The Rat Atlas in Stereotaxic Coordinates, 4th edn. Academic Press: San Diego, CA.
32. Pedata F, Sorbi S, Pepeu G (1980). Choline high-affinity uptake and metabolism and choline acetyltransferase activity in the striatumof rats chronically treated with neuroleptics.J Neurochem35:606-611.
33. Peet M, Glen I, Horrobin D (1999).Phospholipid Spectrum Disorders in Psychiatry.Marius Press: Lancashire, UK.
34. Prince JA, Yassin MS, Oreland L (1997).Neuroleptic-induced mitochondrial enzyme alterations in the rat brain.J PharmacolExpTher280: 261-267.
35. Reddy R, Yao J (1996). Free radical pathology in schizophrenia: a review.Prostaglandins LeukotEssent Fatty Acids55: 33-43.
36. Risse SC, Barnes RJ (1986). Pharmacologic treatment of agitation associated with dementia.J Am Geriatric Soc34: 368-376.
37. Schneider LS, Pollock VE, Lyness SA (1990). A meta-analysis of controlled trials of neuroleptic treatment in dementia.J AmGeriatric Soc38: 553-563.
38. Sharma T, Mockler D (1998). The cognitive efficacy of atypical antipsychotics in schizophrenia.J ClinPsychopharmacol18(2Suppl 1): 12S-19S Related Articles, Books, Link Out.
39. Skarsfeldt T (1996). Differential effect of antipsychotics on place navigation of rats in the Morris water maze.A comparative studybetween novel and reference antipsychotics.Psychopharmacol-ogy (Berl)124: 126-33.
40. Subramanyam B, Pond SM, Eyles DW, Whiteford HA, Fouda HG, CastagnoliJr N (1991). Identification of potentially neurotoxicpyridinium metabolite in the urine of schizophrenic patientstreated with HAL.BiochemBiophys Res Commun181: 573-578.
41. Terry Jr AV (2000). Spatial navigation (water maze) tasks. In Buccafusco JJ (ed).Behavioral Methods in Neuroscience.CRCPress: Boca Raton, FL. pp 153-166.
42. Tollefson GD (1996). Cognitive function in schizophrenic patients.J Clin Psychiatry57(Suppl 11): 31-39.
43. Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT (1998). Markers of glutaminergic neurotransmission and oxidative stress associatedwith Tardive dyskinesia.Am J Psychiatry155: 1207-1213.
44. Wadenberg M-LG, Soliman A, Vanden-Spek SC, Kapur S (2001). Dopamine D2 receptor occupancy is a common mechanismunderlying animal models of antipsychotics and their clinicaleffects.Neuropsychopharmacology25: 633-641.
45. Winkler J, Ramirez GA, Thal LJ, Waite JJ (2000). Nerve growth factor (NGF) augments cortical and hippocampal cholinergicfunctioning after p75NGF receptor-mediated deafferentiationbut impairs inhibitory avoidance and induces fear-relatedbehaviors.J Neurosci20: 834-844.